Your browser doesn't support javascript.
loading
A combination of PD­1/PD­L1 inhibitors: The prospect of overcoming the weakness of tumor immunotherapy (Review).
Kong, Xianbin; Lu, Peng; Liu, Chuanxin; Guo, Yuzhu; Yang, Yuying; Peng, Yingying; Wang, Fangyuan; Bo, Zhichao; Dou, Xiaoxin; Shi, Haoyang; Meng, Jingyan.
Afiliación
  • Kong X; Integrated Traditional Chinese and Western Medicine Laboratory, College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R. China.
  • Lu P; State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R. China.
  • Liu C; Department of Pharmaceutical Analysis, School of Chinese Materia Medical, Beijing University of Chinese Medicine, Beijing 102488, P.R. China.
  • Guo Y; Department of Radiotherapy, Tianjin Hospital, Tianjin 300211, P.R. China.
  • Yang Y; Integrated Traditional Chinese and Western Medicine Laboratory, College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R. China.
  • Peng Y; Integrated Traditional Chinese and Western Medicine Laboratory, College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R. China.
  • Wang F; Integrated Traditional Chinese and Western Medicine Laboratory, College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R. China.
  • Bo Z; Integrated Traditional Chinese and Western Medicine Laboratory, College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R. China.
  • Dou X; Integrated Traditional Chinese and Western Medicine Laboratory, College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R. China.
  • Shi H; Integrated Traditional Chinese and Western Medicine Laboratory, College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R. China.
  • Meng J; Integrated Traditional Chinese and Western Medicine Laboratory, College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R. China.
Mol Med Rep ; 23(5)2021 05.
Article en En | MEDLINE | ID: mdl-33760188
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Inhibidores de Puntos de Control Inmunológico / Neoplasias Límite: Humans Idioma: En Revista: Mol Med Rep Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Inhibidores de Puntos de Control Inmunológico / Neoplasias Límite: Humans Idioma: En Revista: Mol Med Rep Año: 2021 Tipo del documento: Article